Latest Sales Growth News

Xenitra Limited's OPAL Real World Asset tokenised sales ecosystem has generated over $500,000 in sales within its first month, onboarding more than 130 distributors and positioning the company as an early mover in blockchain-enabled FMCG sales in China.

Bapcor reports a turnaround in sales momentum after February 2026 but lowers its full-year earnings forecast due to geopolitical and cost pressures.

Accent Group has laid out an ambitious Vision 2030 strategy aiming for $1.9 billion in sales and a 9%+ EBIT margin. Central to this plan is the expansion of Sports Direct stores and a focus on operational efficiencies and brand evolution.

Zimi Limited has increased its placement commitments by A$100,000 from a sophisticated investor, bringing total funds raised to A$1.56 million ahead of shareholder approval.

Magontec Limited reported a robust first quarter in 2026, with gross profit surging 63% and metals sales volumes up 58%, driven by margin improvements and strategic expansion in electronic anodes and magnesium alloys.

MyEco Group is rolling out a new 95% post-consumer recycled bin liner range, fully certified under the Global Recycled Standard, exclusively at Woolworths stores nationwide from late May 2026. This move doubles its Woolworths product lineup and aligns with national sustainability targets.

Neuren Pharmaceuticals saw a 20% jump in Q1 2026 DAYBUE net sales to US$101 million, with royalties up 23%. The Japan trofinetide trial has been fast-tracked, and the new powder formulation DAYBUE STIX gains early traction.

Xenitra Limited has secured $1.25 million through a share placement to accelerate its OTC medicines rollout and expand its OPAL RWA token ecosystem, with shareholder approval pending for attached options.

Amcor posted a 77% jump in Q3 net sales fueled by the Berry acquisition, delivering synergy gains above expectations and updating fiscal 2026 guidance amid geopolitical headwinds.

Me Today has raised its full-year revenue forecast to over NZD 7.4 million, driven by strong domestic sales and a new exclusive distribution deal in Southeast Asia. The nutritional supplements company also expects a 25% reduction in EBITDA loss, reflecting tighter cost control amid ongoing product innovation.

Super Retail Group reports a subdued second half in FY26 with 0.4% like-for-like sales growth, impacted by geopolitical tensions and inflation, while costs rise to $66 million due to accelerated projects.

The GPT Group delivered strong operational results in Q1 2026 with near-record occupancy across retail, office, and logistics assets, alongside solid retail sales and leasing activity. The group’s $610 million oversubscribed equity raise in its Wholesale Shopping Centre Fund underpins growth plans, while FY 2026 earnings guidance is reiterated.